Serum protein binding of propofol in critically ill patients

Authors:

Abstract
Background: Disease‐induced modifications in the level of serum proteins may change the degree of binding of drugs highly bound to serum proteins.Methods: The serum protein binding of propofol, an intravenous anaesthetic agent, was studiedin vitroin samples of serum from healthy volunteers (n = 28) and from critically ill patients (n = 17). The free fraction was obtained by the ultrafiltration technique and was measured by high‐performance liquid chromatography. Concentrations of serum albumin, α1acid‐glycoprotein and free fatty acids were also measured in all samples.Results: The percentage of free propofol was significantly increased (P< 0.001) in critically ill patients (1.31 (1.06–2.25)%) vs control subjects (1.07 (0.49–1.47)%). Albumin levels were significantly decreased (P‐1vs 45.8 (31.4–55.5) g–1“1), while levels of α1‐acid‐glycoprotein were increased (P‐1vs 0.9 (0.5–1.4) g 1‐1), as were levels of free fatty acids (0.68 (0.50–1.14) mmol I‐1vs 0.37 (0.11–1.05) mmol I‐1;P< 0.05). No correlation was found between levels of α1–acid–glycoprotein or free fatty acids and the bound/free ratio of propofol. However, a linear relationship was found between levels of albumin and the bound/free ratio (r2=O.25;P< 0.001).Conclusion: In conclusion, in these critically ill patients, an increase in the percentage of free propofol occurs. The significance of this observation remains uncertain, but may be validated in future studies. However, the observation supports the common idea that potent drugs should be given with great care in critically ill patients.

This publication has 23 references indexed in Scilit: